This inventor holds 1 USPTO granted patent. Top assignee: Pharmachim. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Diana M Mondeschka: Innovator in Glaucoma Treatment
Introduction
Diana M Mondeschka is a notable inventor based in Sofia, Bulgaria. She has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. Her innovative work has led to the development of a unique composition aimed at alleviating this serious eye condition.
Latest Patents
Diana holds a patent for a composition and method for treating glaucoma. This antiglaucoma composition contains as the active component a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The composition is designed to be used as an ophthalmic solution, with a recommended therapeutic dose of 2 to 3 drops administered two to four times daily to a warm-blooded animal suffering from glaucoma.
Career Highlights
Diana is currently employed at Pharmachim, where she continues to innovate and develop new treatments. Her dedication to research and development has positioned her as a key player in her field.
Collaborations
Diana collaborates with several professionals in her industry, including Marko T Markov and Chavdar B Ivanov. These partnerships enhance her research efforts and contribute to the advancement of glaucoma treatment.
Conclusion
Diana M Mondeschka's contributions to glaucoma treatment through her innovative patent demonstrate her commitment to improving patient care. Her work at Pharmachim and collaborations with fellow professionals highlight her role as a significant inventor in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile